NCT05732194View on ClinicalTrials.gov

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 18, 2023

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

ITI-333

ITI-333 oral solution

OTHER

Placebo

Matching placebo

Trial Locations (1)

33014-3616

Clinical Site 1, Miami

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Intra-Cellular Therapies, Inc.

INDUSTRY